-+ 0.00%
-+ 0.00%
-+ 0.00%

ANAVEX LIFE SCIENCES PRESENTS NEW DATA FROM ITS AD-004 PHASE IIB/III TRIAL AT AD/PD 2026 CONFERENCE DEMONSTRATING CONSISTENT CORRELATION BETWEEN THE TREATMENT EFFECT OF ORAL BLARCAMESINE AND PRESERVATION OF BRAIN VOLUME IN EARLY ALZHEIMER’S DISEASE

Reuters·03/23/2026 11:30:00

Please log in to view news